ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
17 hedge funds and large institutions have $4.58M invested in Aridis Pharmaceuticals Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
Holders
17
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$7.53K | |
| 3 | +$6.77K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.32K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$320 |
Top Sellers
| 1 | -$51K | |
| 2 | -$47K | |
| 3 | -$14.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$9.81K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |